After 30 years as a top pediatrician, Dr. Hilary Cass took on the task of reviewing England’s guidelines for treating children with gender distress. The review revealed weaknesses in the evidence supporting puberty-blocking drugs and hormonal medications for adolescents. Dr. Cass emphasized the need to consider the broader challenges faced by these young people and to provide more holistic support. The report also expressed concerns about the rapid increase in teens seeking gender care and the potential influence of social media. While the response in Britain has been generally supportive, the American Academy of Pediatrics and the Endocrine Society have expressed differing views, with the former declining to comment on the report. Dr. Cass highlighted the importance of evidence-based and ethical decision-making in healthcare, emphasizing the need for a nuanced approach to address the diverse needs of gender-questioning young people.